PLK1 inhibitor or siRNA targeting PLK1 blocked the proliferation of AML cell lines, while the normal hematopoietic progenitors were less sensitive to abolishment of PLK1 [60]. The gene discussed is PLK1; the disease is acute myeloid leukemia.